1) Rosenberg SA. The low-grade non-Hodgkin's lymphomas:challenges and opportunities. J Clin Oncol 3:299-310, 1985
2) Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
3) Czuczman MS, Grillo-Lopez AJ, White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17:268-276, 1999
4) Czuczman MS, Weaver R, Alkuzweny B, et al. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy:9-year follow-up. J Clin Oncol 22:4711-4716, 2004
5) Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma?Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 14:1282-1290, 1996
6) Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract:a study of 25 cases and a literature review. Ann Oncol 14:623-629, 2003
7) de Jong D. Molecular pathogenesis of follicular lymphoma:a cross talk of genetic and immunologic factors. J Clin Oncol 23:6358-6363, 2005
8) Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004